Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06458335

Intervening on Opioid Use and Loneliness

Addressing Loneliness as a Therapy Target Among Individuals Using Opioids

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to enroll 300 participants who will be assigned to one of three 3 groups. Each group will receive an intervention lasting 6, weekly sessions of 40-60 minutes. Eligibility include having an opioid use disorder and reporting loneliness or feeling alone or disconnected.

Detailed description

Individuals (n = 300) with an opioid use disorder reporting loneliness will be randomized to either (1) therapist-delivered cognitive-behavioral therapy for perceived social isolation, (2) therapist-delivered Health Education, or (3) self-guided Health Education. Loneliness, opioid and other substance use, the amount of social interactions, social support, and mental and physical health factors prior to starting the treatment, after completing the treatment, and 1, 3, and 6 months following the treatment will be assessed to see how well they work compared to each other.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive-Behavioral Therapy for Perceived Social Isolation6 sessions focused on addressing thoughts, emotions, and behaviors that maintain feeling alone as a way to reduce loneliness and substance use
BEHAVIORALHealth EducationHealth education provides information on the importance and benefits of and guidelines for living a health lifestyle

Timeline

Start date
2024-09-19
Primary completion
2029-06-30
Completion
2029-06-30
First posted
2024-06-13
Last updated
2025-12-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06458335. Inclusion in this directory is not an endorsement.